Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04459273
What this trial is testing

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Who this might be right for
Bladder CarcinomaCervical CarcinomaCholangiocarcinoma+13 more
Jonsson Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Not applicableEnrolling By InvitationNCT06925685
What this trial is testing

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Who this might be right for
Hematologic MalignanciesSolid Tumors
Allogene Therapeutics 50
Large-scale testing (Phase 3)Study completedNCT04620369
What this trial is testing

Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmNasal Vestibulitis
Mayo Clinic 106
Not applicableLooking for participantsNCT05768269
What this trial is testing

Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Who this might be right for
Hematological MalignancySolid Tumor Malignancy
Century Therapeutics, Inc. 375
Not applicableStudy completedNCT05024331
What this trial is testing

A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor

Who this might be right for
Pediatric Solid Tumor
Samsung Medical Center 10
Not applicableStudy completedNCT05132842
What this trial is testing

Cannabis Use Patterns Among Cancer Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 1,568
Testing effectiveness (Phase 2)Study completedNCT00410696
What this trial is testing

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Who this might be right for
Hematological NeoplasmsTumors
Armando Santoro, MD 80
Not applicableActive Not RecruitingNCT02515383
What this trial is testing

Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 41
Not applicableUnknownNCT06339541
What this trial is testing

The ACC Preclinical Research Platform for Precision Oncology

Who this might be right for
Solid TumorHematologic Neoplasms
Fondazione del Piemonte per l'Oncologia 250
Early research (Phase 1)WithdrawnNCT04605614
What this trial is testing

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center
Early research (Phase 1)Study completedNCT03886831
What this trial is testing

PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

Who this might be right for
Relapsed/Refractory Advanced Solid TumorsRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Myelodysplasia+5 more
Prelude Therapeutics Incorporated 232
Early research (Phase 1)Temporarily pausedNCT03722186
What this trial is testing

Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies

Who this might be right for
Physiological Effects of DrugsNeoplasms by Histologic TypeLymphoma+3 more
Jiangsu HengRui Medicine Co., Ltd. 128
Early research (Phase 1)Ended earlyNCT02706392
What this trial is testing

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more
Fred Hutchinson Cancer Center 21
Not applicableActive Not RecruitingNCT04960787
What this trial is testing

Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
SWOG Cancer Research Network 331
Early research (Phase 1)Ended earlyNCT00070239
What this trial is testing

Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439175
What this trial is testing

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Looking for participantsNCT05159245
What this trial is testing

The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs

Who this might be right for
Advanced CancerSolid TumorHaematological Malignancy
Helsinki University Central Hospital 250
Not applicableStudy completedNCT05045963
What this trial is testing

Impact of Aminoglycosides in Hypotensive Septic Oncology Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSepticemia
M.D. Anderson Cancer Center 232
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Next Page